Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103214568B details Fmoc solid phase secretin synthesis. Achieves over 50% yield and 99% purity. Offers scalable solutions for pharmaceutical supply chains.
Advanced patent-based synthesis of Tetrabenazine intermediate offering high purity and yield. Reliable supply chain solutions for API manufacturing cost reduction.
Patent CN112724180B reveals a novel NMN synthesis method with high selectivity. Discover cost-effective manufacturing solutions for pharmaceutical intermediates and nutraceutical ingredients.
Patent CN114478632B reveals high-ee chiral ligands for hydroformylation. Enhance supply chain reliability and reduce manufacturing costs with scalable synthesis.
Patent CN109796325A reveals efficient synthesis. Reduces cost and improves supply chain reliability for antifungal drug manufacturing.
Patent CN108658853B details a metal-free synthesis of 4-azaaryl alkanols using hypervalent iodine. Offers high atom economy and mild conditions for API intermediate manufacturing.
Patent CN1226275C details a high-yield asymmetric conversion process for D-phenylalanine production offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101830893A details a mild, high-yield synthesis for HDMS. This process offers significant cost reduction and supply chain reliability for antiviral API manufacturing.
Novel phenylboronic acid complexation method enhances troxerutin purity to 97.5 percent while simplifying operations for cost reduction in API manufacturing supply chains.
Patent CN112500379B reveals a high-purity Olaparib synthesis route. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN111303006B reveals a safer, cost-effective route for amlodipine intermediates, eliminating hazardous NaH and ensuring stable supply chains for global pharma manufacturers.
Novel synthesis of Netupitant intermediate avoiding Pd catalysts. High yield, mild conditions, scalable for pharma supply chains.
Patent CN115850144A reveals a streamlined Ezetimibe preparation method, offering significant yield improvements and cost reduction in API manufacturing for global supply chains.
Patent CN101343267A reveals novel inclusion resolution for Pantoprazole. Achieve high purity and stability with reduced manufacturing costs for supply chains.
Patent CN104151352B reveals a high-purity Sofosbuvir intermediate method. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN1161689A enables high-purity levobupivacaine production with reduced resolving agent usage and improved supply chain reliability for pharmaceutical manufacturers globally.
Novel oxidation method for clausenamide production offering high stereochemical control and cost efficiency compared to plant extraction.
Novel patent CN118638011A offers safer chloramphenicol intermediate synthesis. High yield, reduced hazards, reliable supply chain for pharmaceutical manufacturing.
Novel methanol-based process enhances Z 6000 content and reduces impurities for reliable troxerutin supply chain stability and cost efficiency.
Patent CN114478454A reveals a convergent synthesis for SGLT2 inhibitors, offering significant cost reduction in API manufacturing and improved supply chain reliability.